Neuropathological Correlates of Dementia in Alzheimer’s Disease
暂无分享,去创建一个
[1] E. Masliah,et al. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE , 1997, Brain Research.
[2] C. Heyser,et al. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] Alistair Burns,et al. Diagnosis of Alzheimer's Disease , 1997, International Psychogeriatrics.
[4] E. Masliah,et al. ALTERATIONS IN APOLIPOPROTEIN E EXPRESSION DURING AGING AND NEURODEGENERATION , 1996, Progress in Neurobiology.
[5] E. Masliah,et al. Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease , 1996 .
[6] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[7] M. Pericak-Vance,et al. Genetic studies in Alzheimer's disease with an NACP/α‐synuclein polymorphism , 1996 .
[8] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[9] D. Salmon,et al. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease , 1996, Brain Research.
[10] A. Brun,et al. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. , 1996, Dementia.
[11] B. Strooper,et al. 801 Expression in brain of Amyloid Precursor Protein mutated in the α-secretase site, causes disturbed behavior, neuronal degeneration and premature death in transgenic mice , 1996, Neurobiology of Aging.
[12] J. Price,et al. Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.
[13] D. Galasko,et al. Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[14] J. Gilbert,et al. Morphological, Biochemical, and Genetic Support for an Apolipoprotein E Effect on Microtubular Metabolism a , 1996, Annals of the New York Academy of Sciences.
[15] E. Masliah,et al. Patterns of neurodegeneration in HIV encephalitis. , 1995, Journal of neuro-AIDS.
[16] E. Masliah,et al. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. , 1996, The American journal of pathology.
[17] S. Gauthier,et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[18] Brian J Cummings,et al. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity , 1995, The Lancet.
[19] A. Roses,et al. Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.
[20] I. Mena,et al. SPECT in Dementia: Clinical and Pathological Correlation , 1995, Journal of the American Geriatrics Society.
[21] D. Michaelson,et al. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice , 1995, Neuroscience Letters.
[22] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Finch,et al. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. , 1995, Brain research. Molecular brain research.
[24] H. Chui,et al. Multicenter clinicopathological correlation in dementia. , 1995, The American journal of psychiatry.
[25] M. Yoshimoto,et al. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] F. Gage,et al. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion , 1995, Neuroscience.
[27] J. Hauw,et al. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease , 1995, Neurobiology of Aging.
[28] L. K. Rasmussen,et al. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide. , 1995, The Biochemical journal.
[29] E. Masliah,et al. Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. , 1995, Biochemistry.
[30] M. Romero,et al. Electrogenic Properties of the Epithelial and Neuronal High Affinity Glutamate Transporter (*) , 1995, The Journal of Biological Chemistry.
[31] A. Levey,et al. Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.
[32] E. Masliah,et al. PDGF is associated with neuronal and glial alterations of Alzheimer's disease , 1995, Neurobiology of Aging.
[33] D. Munoz,et al. Qualitative and Quantitative Differences in Senile Plaque Dystrophie Neurites of Alzheimer's Disease and Normal Aged Brain , 1995, Journal of neuropathology and experimental neurology.
[34] A D Roses,et al. Apolipoprotein E and Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Dawson,et al. β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity , 1995, Cell.
[36] E. Masliah. Natural evolution of the neurodegenerative alterations in Alzheimer's disease , 1995, Neurobiology of Aging.
[37] W. Honer,et al. Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.
[38] P. Coleman,et al. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease , 1995, Neurobiology of Aging.
[39] P. Dodd,et al. Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex , 1995, Journal of neurochemistry.
[40] S Lehéricy,et al. Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[41] E. Masliah,et al. Mechanisms of synaptic dysfunction in Alzheimer's disease. , 1995, Histology and histopathology.
[42] L. Mucke,et al. Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein , 1995, The Journal of experimental medicine.
[43] A. Roses,et al. The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis. , 1995, Genomics.
[44] R. Heilig,et al. The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease. , 1995, Genomics.
[45] E. Masliah,et al. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. , 1995, Neuroreport.
[46] J. Tateishi,et al. Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease , 1995, Journal of the Neurological Sciences.
[47] P. Andersen,et al. Possible strategies for finding the substrate for learning-induced changes in the hippocampal cortex. , 1995, Journal of neurobiology.
[48] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[49] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[50] H. Soininen,et al. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease , 1995, Neuroscience.
[51] D. Rusakov,et al. Morphological changes associated with stages of memory formation in the chick following passive avoidance training , 1995, Behavioural Brain Research.
[52] W. Orrison,et al. Atlas of Brain Function , 1995 .
[53] M. Gearing,et al. The CERAD experience, part VIII , 1995, Neurology.
[54] B. Anderson. DENDRITIC CORRELATES OF DEMENTIA SEVERITY IN ALZHEIMER'S DISEASE , 1995 .
[55] D.G. Jones,et al. An Analysis of Contemporary Morphological Concepts of Synaptic Remodelling in the CNS: Perforated Synapses Revisited , 1995, Reviews in the neurosciences.
[56] L. Mucke,et al. Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. , 1995, Current topics in microbiology and immunology.
[57] A. Smith,et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. , 1995, Dementia.
[58] L Carlin,et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. , 1995, Archives of neurology.
[59] J. Poirier. Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.
[60] D. Clair,et al. Synuclein proteins and Alzheimer's disease , 1994, Trends in Neurosciences.
[61] W. Honer,et al. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease , 1994, Brain Research.
[62] L. Mucke,et al. Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice , 1994, Brain Research.
[63] D. Price,et al. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. , 1994, The American journal of pathology.
[64] L. R. Hill,et al. Hippocampal connectivity and Alzheimer's dementia , 1994, Neurology.
[65] R. Porter,et al. Anatomy and physiology of glutamate in the CNS , 1994, Neurology.
[66] J. Morrison,et al. Neuron-specific human glutamate transporter: molecular cloning, characterization and expression in human brain , 1994, Brain Research.
[67] M. Trucco,et al. Cloning and characterization of a glutamate transporter cDNA from human brain and pancreas. , 1994, Biochimica et biophysica acta.
[68] L A Hansen,et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.
[69] M. Hediger,et al. The neuronal and epithelial human high affinity glutamate transporter. Insights into structure and mechanism of transport. , 1994, The Journal of biological chemistry.
[70] E. Masliah,et al. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[71] N Butters,et al. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. , 1994, Archives of neurology.
[72] R. Levy,et al. Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease , 1994, British Journal of Psychiatry.
[73] E. Masliah,et al. Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.
[74] W. Müller,et al. Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. , 1994, Biochemical and biophysical research communications.
[75] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[76] J. Higaki,et al. Increased amyloid production from aberrant beta-amyloid precursor proteins. , 1994, The Journal of biological chemistry.
[77] D. Small,et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[78] A Hirano,et al. Hirano bodies and related neuronal inclusions , 1994, Neuropathology and applied neurobiology.
[79] Margaret A. Pericak-Vance,et al. Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.
[80] J. Kimura,et al. Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains , 1994, Brain Research.
[81] ML Voytko,et al. Basal forebrain lesions in monkeys disrupt attention but not learning and memory [published erratum appears in J Neurosci 1995 Mar;15(3): following table of contents] , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[82] C. Lippa,et al. Alzheimer's disease and Lewy body disease: A comparative clinicopathological study , 1994, Annals of neurology.
[83] E. Masliah,et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[84] K. Jellinger,et al. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients , 1993, Neuroscience Letters.
[85] E. Masliah,et al. Atypical diffuse Lewy body disease with neuritic abnormalities. , 1993, Clinical neuropathology.
[86] S. Nakajo,et al. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. , 1993, European journal of biochemistry.
[87] E. Masliah,et al. Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa , 1993, Journal of neuropathology and experimental neurology.
[88] I. McKeith,et al. Single Photon Emission Computerised Tomography in Elderly Patients with Alzheimer's Disease and Multi-infarct Dementia , 1993, British Journal of Psychiatry.
[89] T. Deerinck,et al. Re‐Evaluation of the Structural Organization of Neuritic Plaques in Alzheimer's Disease , 1993 .
[90] M. Mattson,et al. Mechanisms of Neurotrophic Factor Protection against Calcium- and Free Radical-Mediated Excitotoxic Injury: Implications for Treating Neurodegenerative Disorders , 1993, Experimental Neurology.
[91] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[92] D. Selkoe. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease , 1993, Trends in Neurosciences.
[93] E. Masliah,et al. The synaptic organization of the neocortex in Alzheimer's disease. , 1993, Medical hypotheses.
[94] M. Mattson,et al. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF , 1993, Brain Research.
[95] D. Sparks,et al. Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease , 1993, Annals of neurology.
[96] P. Seeburg. The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels , 1993, Trends in Neurosciences.
[97] Yoshikatsu Kanai,et al. The elusive transporters with a high affinity for glutamate , 1993, Trends in Neurosciences.
[98] R. Levy,et al. Neuropathological Correlates of Behavioural Disturbance in Confirmed Alzheimer's Disease , 1993, British Journal of Psychiatry.
[99] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[100] Michael Alford,et al. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies , 1993, Brain Research.
[101] J. Rothstein,et al. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[102] S. Gauthier,et al. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats , 1993, Neuroscience.
[103] Y. Agid,et al. Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins , 1993, Annals of neurology.
[104] J. Miller,et al. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. , 1993, Archives of neurology.
[105] E. Masliah,et al. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. , 1993, The American journal of pathology.
[106] K. Beyreuther,et al. Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. , 1993, Dementia.
[107] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[108] M. Mattson,et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.
[109] S. Mirra,et al. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. , 1993, Archives of pathology & laboratory medicine.
[110] D. Price,et al. Synapse loss in the temporal lobe in Alzheimer's disease , 1993, Annals of neurology.
[111] E. Masliah,et al. The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System , 1993, Brain pathology.
[112] G. Clincke,et al. Synaptic plasticity in rat hippocampus associated with learning , 1992, Behavioural Brain Research.
[113] R. Levy,et al. Clinical and neuropathological correlates of depression in Alzheimer's disease , 1992, Psychological Medicine.
[114] A. Shetter,et al. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations , 1992 .
[115] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[116] N. Inestrosa,et al. Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases , 1992, Neuroscience Letters.
[117] Bradley T. Hyman,et al. Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.
[118] J. Morrison,et al. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. , 1992, Archives of neurology.
[119] K. Lu,et al. Protein synthesis in the hippocampus associated with memory facilitation by corticotropin-releasing factor in rats , 1992, Peptides.
[120] W. Engel,et al. Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions , 1992, Neuroscience Letters.
[121] B Carragher,et al. Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease , 1992, Journal of neuropathology and experimental neurology.
[122] D. Drachman,et al. Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses , 1992, Neurobiology of Aging.
[123] W. Honer,et al. Regional synaptic pathology in Alzheimer's disease , 1992, Neurobiology of Aging.
[124] K. Obata,et al. Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease , 1992, Neuroscience Letters.
[125] E. Masliah,et al. Cortical dendritic pathology in human immunodeficiency virus encephalitis. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[126] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[127] D. Selkoe,et al. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.
[128] K. Jellinger,et al. Synaptic pathology in alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles , 1992, Neuroscience.
[129] W. Honer,et al. Characterization of a synaptic antigen of interest in neuropsychiatric illness , 1992, Biological Psychiatry.
[130] M. Vandermeeren,et al. Neurite sprouting and cytoskeletal pathology in Alzheimer's disease: a comparative study with monoclonal antibodies to growth associated protein B-50 and paired helical filaments , 1992 .
[131] Dallas E. Johnson,et al. Analysis of messy data , 1992 .
[132] Yi Li,et al. Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. , 1992, Life sciences.
[133] P. Ince,et al. Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease , 1991, Annals of the New York Academy of Sciences.
[134] Walter Schubert,et al. Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites , 1991, Brain Research.
[135] R. Scheller,et al. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. , 1991, Brain research. Molecular brain research.
[136] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[137] D. Dickson,et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.
[138] E. Masliah,et al. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies , 1991, Neuroscience Letters.
[139] K. Kosik,et al. Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.
[140] M. Tabaton,et al. Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[141] Michael Alford,et al. Patterns of aberrant sprouting in alzheimer's disease , 1991, Neuron.
[142] V. Lee,et al. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[143] J. Morrison,et al. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease , 1991, Experimental Neurology.
[144] E. Masliah,et al. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. , 1991, The American journal of pathology.
[145] E. Masliah,et al. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. , 1990, The American journal of pathology.
[146] Kevin Cox,et al. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.
[147] L. Wolfson,et al. Antemortem diagnosis of diffuse Lewy body disease , 1990, Neurology.
[148] S. Gershon,et al. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[149] J. Hardy,et al. Glutamatergic neurotransmission in Alzheimer's disease. , 1990, Biochemical Society transactions.
[150] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.
[151] J. Trojanowski,et al. Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. , 1990, The American journal of pathology.
[152] D. Price,et al. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.
[153] K. Jellinger,et al. A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease , 1990, FEBS letters.
[154] K. Jellinger,et al. Clinicopathological analysis of dementia disorders in the elderly , 1990, Journal of the Neurological Sciences.
[155] Stephen W. Scheff,et al. Quantitative assessment of cortical synaptic density in Alzheimer's disease , 1990, Neurobiology of Aging.
[156] Robert H. Perry,et al. Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.
[157] L. Thal,et al. The Lewy body variant of Alzheimer's disease , 1990, Neurology.
[158] W. Benzing,et al. Substance P and somatostatin coexist within neuritic plaques: Implications for the pathogenesis of Alzheimer's disease , 1989, Neuroscience.
[159] J. Wegiel,et al. Ultrastructural Studies of the Cells Forming Amyloid Fibers in Classical Plaques , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[160] R. Godwin-Austen,et al. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[161] E. Masliah,et al. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease , 1989, Neuroscience Letters.
[162] D. Selkoe. Amyloid β protein precursor and the pathogenesis of Alzheimer's disease , 1989, Cell.
[163] David A. Drachman,et al. Synaptic loss in Alzheimer's disease and other dementias , 1989, Neurology.
[164] S. Styren,et al. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.
[165] D. Selkoe,et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[166] M. Norenberg,et al. Diffuse Lewy body disease and progressive dementia , 1988, Neurology.
[167] Y. Ihara. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease , 1988, Brain Research.
[168] J. Morris,et al. Validation of clinical diagnostic criteria for Alzheimer's disease , 1988, Annals of neurology.
[169] D. Dickson,et al. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. , 1988, The American journal of pathology.
[170] D. Neary,et al. THE PROGRESSION OF THE PATHOLOGICAL CHANGES OF ALZHEIMER'S DISEASE IN FRONTAL AND TEMPORAL NEOCORTEX EXAMINED BOTH AT BIOPSY AND AT AUTOPSY , 1988, Neuropathology and applied neurobiology.
[171] O. Steward,et al. An immunocytochemical and biochemical study of the microtubule-associated protein MAP-2 during post-lesion dendritic remodeling in the central nervous system of adult rats. , 1988, Brain research.
[172] G K Wilcock,et al. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[173] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[174] J. Hardy,et al. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease , 1988, Neuroscience Letters.
[175] H. Braak,et al. Neuropil Threads Occur in Dendrites of Tangle—Bearing Nerve Cells , 1988, Neuropathology and applied neurobiology.
[176] R. Katzman.,et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.
[177] George Perry. Alterations in the Neuronal Cytoskeleton in Alzheimer Disease , 1988, Advances in Behavioral Biology.
[178] O. Steward,et al. An immunocytochemical and biochemical study of the microtubule-associated protein Tau during post-lesion afferent reorganization in the hippocampus of adult rats , 1987, Brain Research.
[179] R. Mahley,et al. Lipoprotein uptake by neuronal growth cones in vitro. , 1987, Science.
[180] S. Mirra,et al. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients , 1987, Neurology.
[181] R. Katzman.,et al. Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles , 1987, Journal of neuropathology and experimental neurology.
[182] D. Mann,et al. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.
[183] G. V. Van Hoesen,et al. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease , 1987, Annals of neurology.
[184] S. Young,et al. Neuronal Fibrillar Cytoskeleton and Endomembrane System Organization in Alzheimer’s Disease , 1987 .
[185] M. Roth,et al. NEURONAL DEGENERATION IN LOCUS CERULEUS AND CORTICAL CORRELATES OF ALZHEIMER DISEASE , 1987, Alzheimer disease and associated disorders.
[186] J. Wade,et al. The clinical diagnosis of Alzheimer's disease. , 1987, Archives of neurology.
[187] L. Sternberger,et al. Lewy Body Dementia Without Alzheimer Changes , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[188] G. V. Van Hoesen,et al. Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.
[189] R. Gregg,et al. Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.
[190] H. Braak,et al. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques , 1986, Neuroscience Letters.
[191] E. Gray. SPONGIFORM ENCEPHALOPATHY: A NEUROCYTOLOGIST'S VIEWPOINT WITH A NOTE ON ALZHEIMER'S DISEASE , 1986, Neuropathology and applied neurobiology.
[192] D. Neary,et al. Alzheimer's disease: a correlative study. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[193] P. Slater,et al. The association of [3H]d-aspartate binding and high-affinity glutamate uptake in the human brain , 1986, Neuroscience Letters.
[194] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[195] J. Rinne,et al. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[196] C. Dotti,et al. Immunocytochemical localization of tubulin and the high molecular weight microtubule-associated protein 2 in purkinje cell dendrites deprived of climbing fibers , 1985, Neuroscience.
[197] J. Taylor,et al. Nucleotide sequence and structure of the human apolipoprotein E gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[198] G. V. Van Hoesen,et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.
[199] R. Mahley,et al. Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.
[200] J. Eccles. The modular operation of the cerebral neocortex considered as the material basis of mental events , 1981, Neuroscience.
[201] R. DeTeresa,et al. Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.
[202] P. Davies. Neurotransmitter-related enzymes in senile dementia of the alzheimer type , 1979, Brain Research.
[203] Robert H. Perry,et al. Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue , 1977, Journal of the Neurological Sciences.
[204] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[205] I. Evangelista,et al. THE CONTRIBUTION OF ALTERED SYNAPSES IN THE SENILE PLAQUE: AN ELECTRON MICROSCOPIC STUDY IN ALZHEIMER'S DEMENTIA , 1967, Journal of neuropathology and experimental neurology.
[206] R. Terry,et al. ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.
[207] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .